New COVID vaccine option being administered through Harris County | Houston Public Media

Lucio Vasquez / Houston Public Media A woman receives a COVID-19 vaccine at the Acres Homes Multi-Service Center on Feb. 16. 2022. The latest COVID-19 vaccine has local health officials feeling optimistic that skeptics will roll up their sleeves and get vaccinated with a new option available. The Novavax vaccine is now the fourth available … Read more

Pfizer to buy South SF-based Global Blood Therapeutics in $5.4B deal

SOUTH SAN FRANCISCO — Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. Pfizer said Monday that the acquisition will boost its work in rare hematology. Global Therapeutics, which was founded in 2011 and is headquartered … Read more

Pfizer In Talks To Buy Drugmaker For $5 Billion: Report

Pfizer is one of the top makers of Covid-19 vaccines.(File) New York: American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported. Pfizer, one of the top makers of Covid-19 vaccines, hopes to conclude … Read more

Health Canada has authorized a COVID vaccine for kids under five. Here’s what you need to know

The Moderna COVID-19 vaccine for kids between the ages of six months and five years has been authorized by Health Canada, making it the first shot to be offered to young children. Many parents are breathing a sigh of relief, in anticipation of what is likely to be the final leg of Canada’s age-based vaccination … Read more

Pfizer gives $1.5M grant to NYC schools’ STEM programs

New York City middle and high schools are set to receive a $1.5 million grant from Pfizer Inc. for science, technology, engineering and math programs, Mayor Eric Adams announced on Monday. The grant was made to the Mayor’s Fund to Advance New York City, according to a City Hall press release. “If we don’t educate, … Read more

FDA Allows Licensed Pharmacists To Prescribe Pfizer’s Paxovid To People Who Are Eligible

SILVER SPRINGS, Md. (CW44 News At 10 | CNN) — The US Food and Drug Administration revised the emergency use authorization for Pfizer’s Covid-19 antiviral treatment, Paxlovid, on Wednesday to allow state-licensed pharmacists to prescribe the treatment to people who are eligible. “The FDA recognizes the important role pharmacists have played and continue to play in … Read more

Here’s what you need to know about a possible fall COVID booster campaign

Get ready to roll up your sleeves again, now that Canada’s national advisory body on vaccines has released guidelines that could lay the groundwork for a fall booster campaign — and dialled up the urgency on recommendations that people sign up for more shots. Broadly speaking, no matter how many previous COVID shots you’ve had, … Read more

U.S. buys 105 million COVID vaccine doses for fall campaign

WASHINGTON — U.S. health officials said Wednesday they have agreed to purchase another 105 million doses of Pfizer’s COVID-19 vaccine in anticipation of a fall booster campaign. The $3.2 billion deal announced by the Biden administration comes as federal scientists consider how to update the vaccines to better protect Americans from the rapidly evolving virus. … Read more

FDA panel votes to include latest omicron variants in fall boosters as LA sees sharp rise in cases

LOS ANGELES (KABC) — Food and Drug Administration advisers voted in favor of updating the new COVID-19 vaccine to include the latest omicron subvariants. An FDA expert panel determined the vaccines should be updated with the BA.4 and BA.5 omicron subvariants. It’s the most current variant. Scientists agreed boosters should also include the original strain. … Read more

EU ombudsman calls Commission response over texts ‘problematic’

The EU’s internal watchdog has criticised as “problematic” the European Commission’s defence over its refusal to release text messages between President Ursula von der Leyen and the CEO of Pfizer. The EU Ombudsman had called on the bloc’s executive to share the controversial exchanges about the EU’s purchase of vaccine contracts. The text exchange was reported by … Read more